Caricamento...
Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery
The past decade has witnessed a paradigm shift in preclinical drug discovery with structure-based drug design (SBDD) making a comeback while high-throughput screening (HTS) methods have continued to generate disappointing results. There is a deficit of information between identified hits and the man...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Research Network of Computational and Structural Biotechnology (RNCSB) Organization
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3962124/ https://ncbi.nlm.nih.gov/pubmed/24688704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5936/csbj.201302011 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|